|Bid||139.86 x 1100|
|Ask||139.96 x 800|
|Day's Range||138.53 - 140.16|
|52 Week Range||127.32 - 160.14|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.13|
|Expense Ratio (net)||0.20%|
The measure of optimism among U.S. small-business owners touched a record on highest capital spending since 2007 and all-time high hiring.
How Is Accelerate Diagnostics Positioned at the Start of 2018? In June 2017, Accelerate Diagnostics (AXDX) raised net proceeds of $83.2 million from a public offering of 2.8 million shares of common stock. As a result of the offering, the cash position of the company increased to $121.3 million at the end of 3Q17 as compared with $77.8 million at the end of 3Q16.